90 related articles for article (PubMed ID: 3301388)
1. Trypanosoma cruzi: inhibition by spirogermanium hydrochloride.
Tanowitz HB; Brennessel DJ; Baum SG; Salgo MP; Braunstein V; Wittner M
Exp Parasitol; 1987 Aug; 64(1):57-63. PubMed ID: 3301388
[TBL] [Abstract][Full Text] [Related]
2. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.
Slavik M; Blanc O; Davis J
Invest New Drugs; 1983; 1(3):225-34. PubMed ID: 6678870
[TBL] [Abstract][Full Text] [Related]
3. Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi.
Santa-Rita RM; Santos Barbosa H; Meirelles MN; de Castro SL
Acta Trop; 2000 Mar; 75(2):219-28. PubMed ID: 10708662
[TBL] [Abstract][Full Text] [Related]
4. Effects of spirogermanium on the in vitro assembly and disassembly of brain microtubules.
Peyrot V; Briand C; Codaccioni F; Sari JC
Chem Biol Interact; 1987 Feb; 61(2):151-8. PubMed ID: 3829141
[TBL] [Abstract][Full Text] [Related]
5. Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium.
Pate PG; Wolfson JS; McHugh GL; Pan SC; Swartz MN
Antimicrob Agents Chemother; 1986 Mar; 29(3):426-31. PubMed ID: 3521485
[TBL] [Abstract][Full Text] [Related]
6. Spirogermanium: a new drug with antimalarial activity against chloroquine-resistant Plasmodium falciparum.
Mrema JE; Slavik M; Davis J
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):167-71. PubMed ID: 6345410
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural alterations and growth inhibition of Trypanosoma cruzi and Leishmania major induced by Bothrops jararaca venom.
Gonçalves AR; Soares MJ; de Souza W; DaMatta RA; Alves EW
Parasitol Res; 2002 Jul; 88(7):598-602. PubMed ID: 12107450
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions.
Mirabelli CK; Badger AM; Sung CP; Hillegass L; Sung CM; Johnson RK; Picker D; Schwartz D; Dorman J; Martellucci S
Anticancer Drug Des; 1989 Mar; 3(4):231-42. PubMed ID: 2930625
[TBL] [Abstract][Full Text] [Related]
9. Mercaptopyridine-N-oxide, an NADH-fumarate reductase inhibitor, blocks Trypanosoma cruzi growth in culture and in infected myoblasts.
Turrens JF; Newton CL; Zhong L; Hernandez FR; Whitfield J; Docampo R
FEMS Microbiol Lett; 1999 Jun; 175(2):217-21. PubMed ID: 10386371
[TBL] [Abstract][Full Text] [Related]
10. The effect of adenosine analogues on the in vitro growth of Trypanosoma cruzi.
Nadler JP; Lederer E; Wittner M; Baum SG; Tanowitz HB
Trans R Soc Trop Med Hyg; 1982; 76(3):285-7. PubMed ID: 7051450
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi: adrenergic modulation of cyclic AMP role in proliferation and differentiation of amastigotes in vitro.
de Castro SL; Meirelles Mde N; Oliveira MM
Exp Parasitol; 1987 Dec; 64(3):368-75. PubMed ID: 2824234
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.
Hill BT; Whatley SA; Bellamy AS; Jenkins LY; Whelan RD
Cancer Res; 1982 Jul; 42(7):2852-6. PubMed ID: 7200828
[TBL] [Abstract][Full Text] [Related]
13. Biological aspects of the Trypanosoma cruzi (Dm28c clone) intermediate form, between epimastigote and trypomastigote, obtained in modified liver infusion tryptose (LIT) medium.
Bourguignon SC; Mello CB; Santos DO; Gonzalez MS; Souto-Padron T
Acta Trop; 2006 Apr; 98(1):103-9. PubMed ID: 16574051
[TBL] [Abstract][Full Text] [Related]
14. Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.
Hill BT; Whelan RD
Invest New Drugs; 1986; 4(4):359-65. PubMed ID: 3583643
[TBL] [Abstract][Full Text] [Related]
15. Effect of L-leucine methyl ester on growth and ultrastructure of Trypanosoma cruzi.
Adade CM; Figueiredo RC; De Castro SL; Soares MJ
Acta Trop; 2007 Jan; 101(1):69-79. PubMed ID: 17250794
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory action of the antitumor agent lonidamine on mitochondrial respiration of Trypanosoma cruzi and T. brucei.
Turrens JF
Mol Biochem Parasitol; 1986 Sep; 20(3):237-41. PubMed ID: 3531848
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi.
Santa-Rita RM; Barbosa HS; de Castro SL
Parasitol Res; 2006 Dec; 100(1):187-90. PubMed ID: 16855821
[TBL] [Abstract][Full Text] [Related]
18. Killing of Trypanosoma cruzi and Leishmania mexicana, and survival of Toxoplasma gondii, in chicken macrophages in vitro.
Meirelles MN; De Souza W
J Submicrosc Cytol; 1985 Jul; 17(3):327-34. PubMed ID: 3894681
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of proteasome activity blocks Trypanosoma cruzi growth and metacyclogenesis.
Cardoso J; Soares MJ; Menna-Barreto RF; Le Bloas R; Sotomaior V; Goldenberg S; Krieger MA
Parasitol Res; 2008 Sep; 103(4):941-51. PubMed ID: 18581141
[TBL] [Abstract][Full Text] [Related]
20. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction.
Menna-Barreto RF; Goncalves RL; Costa EM; Silva RS; Pinto AV; Oliveira MF; de Castro SL
Free Radic Biol Med; 2009 Sep; 47(5):644-53. PubMed ID: 19501647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
